Setsuko K. Chambers, MD, elected to prestigious Institute of Medicine of the National Academies

Dr. Chambers
Dr. Chambers

Setsuko K. Chambers, MD, director of Women’s Cancers at the Arizona Cancer Center has been elected a member of the prestigious Institute of Medicine of the National Academies.

Election to the Institute is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. The Institute’s total active membership numbers 1,610 and there are 93 foreign associates and 75 emeritus members. Dr. Chambers joins a small cadre of obstetricians and gynecologists in the nation who have been similarly honored.

Dr. Chambers, who joined the Arizona Cancer Center in 2004, is the Bobbi Olson Endowed Chair in Ovarian Cancer Research and is the Cancer Center’s Cancer Biology and Genetics Program co-chair. She is a professor and vice chair of the Department of Obstetrics and Gynecology and section head of Gynecologic Oncology at the University of Arizona College of Medicine.

“Becoming a member of the Institute of Medicine of the National Academies is the greatest honor that a physician-scientist can achieve. Dr. Chambers is one of those rare physicians who has been able to achieve excellence in both basic research – in her case, pursuit of specific gene mutations in breast tissue leading to metastatic breast cancer – and clinical oncology with a focus on the surgical and chemotherapy management of ovarian cancer,” said David Alberts, MD, director of the Arizona Cancer Center.

“We are very proud to have Setsuko in the Arizona Cancer Center. I personally enjoy the opportunity to do clinical translational research with her,” Dr. Alberts said.

As a gynecologic oncologist, Dr. Chambers believes in the value that her specialty brings to gynecologic cancer patients and their families. She has expertise in a broad spectrum of areas including prevention, screening, diagnosis, surgery (minimally invasive to radical cancer surgeries), chemotherapy (standard of care to innovative clinical trials of targeted therapeutics) and palliative care, all within the breadth of one specialty. This provides the continuity essential to high-quality patient care and satisfaction. She has a large clinical practice carrying out all of these activities.

Simultaneously, Dr. Chambers stands out as one of the few gynecologic oncologists in the nation who has expertise in basic research, directing a laboratory devoted to understanding the molecular basis for ovarian and breast cancer metastasis; heading a large clinical-trials effort that translates laboratory findings into patient application; building a women’s cancers (breast and gynecologic) effort by promoting retreats, seminars, funding faculty development and research; and by continuing to mentor a dedicated cadre of trainees and junior faculty, many of whom are budding leaders in their field. The breadth of these skills along with her vision of excellence and her tireless advocacy for her programs and causes make Dr. Chambers nationally recognized as an academic leader. As an Institute member, she will continue to pursue excellence and leadership for women’s health at a national level.